Using Wearable Devices to Monitor and Predict Cardiovascular Health and Disease Risk in Adults

What this Trial Is About

Researchers are evaluating how wearable devices, specifically the Fitbit Charge 6, can help assess cardiovascular health and disease risk. The study focuses on people with varying degrees of atherosclerotic cardiovascular disease as well as a subgroup of healthy individuals, using the American Heart Associations Lifes Essential 8 framework to measure heart health. The goal is to understand the relationship between data from wearables and traditional cardiovascular risk factors. Participants will wear the Fitbit Charge 6 continuously for six months, with their biometric data collected throughout the study. They will undergo clinical cardiovascular assessments at the start, midpoint three months, and end of the study, during which their Lifes Essential 8 score will be calculated. Alongside these assessments, participants will complete several questionnaires on physical activity, mental health, sleep quality, and other health behaviors both during visits and weekly or monthly online. During the study, participants will provide continuous wearable data and complete patient-reported outcome measures regularly online. Researchers will monitor changes in wearable biometrics and their association with cardiovascular health scores and risk factors. The study will also classify cardiovascular health tiers and track mental, behavioral, and sleep-related factors. This observational study will last for six months of active monitoring to collect comprehensive data on cardiovascular health.

Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.